TN Army National Guard MMR and VARIVAX Vaccines
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
W7N1 USPFO ACTIVITY TN ARNG
Contract Value
Not provided
Codes & Classification
Solicitation Number
W912L726Q1403
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Tennessee Army National Guard (TNARNG), through its Purchasing and Contracting Office for the United States Property and Fiscal Office (USPFO) located at 3041 Sidco Drive, Nashville, TN 37204, has issued a combined synopsis/solicitation for the procurement of MMR (Measles, Mumps, and Rubella) and VARIVAX (Varicella) vaccines. This procurement is structured as a Request for Quote (RFQ) and is intended to result in a single award, firm fixed price contract. The solicitation is conducted in accordance with Federal Acquisition Regulation (FAR) subpart 12, which governs the acquisition of commercial items, and incorporates all relevant provisions and clauses as updated by Federal Acquisition Circular (FAC) 2026-06, effective March 13, 2026.
The primary objective of this procurement is to secure a reliable supply of MMR and VARIVAX vaccines for the TNARNG, supporting the health and readiness of its personnel. The scope of the contract encompasses the delivery of these pharmaceutical preparations, with the expectation that the awarded contractor will provide products that meet all applicable regulatory standards for safety, efficacy, and quality.
This opportunity is classified under NAICS code 325412, Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, which pertains to drugs and biologicals. The procurement is open to qualified vendors capable of manufacturing or supplying these vaccines in compliance with federal requirements.
The contracting activity is managed by W7N1 USPFO ACTIVITY TN ARNG, a federal office under the Department of Defense and the Department of the Army. Interested parties are encouraged to review the attached solicitation for comprehensive details regarding submission requirements, evaluation criteria, and contract terms. While no set-aside requirements or special considerations are specified in the provided information, contractors should ensure their offerings align with the stated NAICS and product codes.
Key contacts for this solicitation include Sinamar Benauro ([email protected], 629-332-6224) and Teresa Baxter ([email protected], 629-332-6424), who can provide additional information or clarification as needed.
The solicitation was posted on October 4, 2026, with responses due by April 23, 2026, at 16:04. The notice remains active and is accessible via the SAM.gov portal at the provided URL. Contractors with capabilities in pharmaceutical preparation manufacturing, particularly those experienced in supplying vaccines to federal entities, are encouraged to consider this opportunity.